Search

everythinglearnresearchcommunity

for

Search:↓

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Keratosis pilaris is a common skin condition where hair follicles get clogged with keratin, mostly on the arms and thighs.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

Endovascular repair and open surgery for abdominal aortic aneurysms both result in a temporary decline in physical health, with no significant mental health difference, and a return to near normal health in 90 days.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Scalp pain should be classified as a type of headache.

Possible link between COVID-19 and hair loss; more research needed.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Alternative treatments show promise for hair growth beyond traditional methods.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Zebrafish larvae are used to study and find treatments for ear cell damage because they are easier to observe and test than mammals.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

A specially designed molybdenum oxide nanozyme can treat and monitor acute kidney injury effectively.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Lower SHBG levels may increase the risk of PCOS.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.